Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00601965 · ClinicalTrials.gov registry record · NA
Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
A NA study of Generalized Anxiety Disorder, sponsored by Veterans Medical Research Foundation.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
- 3
- Study locations
NCT00601965 is a NA study of Generalized Anxiety Disorder that has completed, run by Veterans Medical Research Foundation. The registered enrollment target is 73 participants, below the 213-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (66% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00601965, a NA study of Generalized Anxiety Disorder, has completed, sponsored by Veterans Medical Research Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Escitalopram
- BEHAVIORAL Cognitive behavioral therapy (CBT)
Study Locations (3)
California
- UCSD Outpatient Psychiatric Services - San Diego
Missouri
- Washington University - St Louis
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00601965
The ClinicalTrials.gov registry entry for NCT00601965 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 213-participant average among 48 other Generalized Anxiety Disorder trials with a reported enrollment target (66% lower). The listed sponsor is Veterans Medical Research Foundation, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Generalized Anxiety Disorder appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT00601965 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Missouri, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00601965 about?
NCT00601965 is a clinical study titled "Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults". This study will assess whether adding cognitive behavioral therapy to the antidepressant escitalopram is effective in reducing anxiety in older adults with generalized anxiety disorder.
What is the current status of trial NCT00601965?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2007-10. Estimated completion is 2011-09.
What conditions does trial NCT00601965 study?
This clinical trial studies the following conditions: Generalized Anxiety Disorder.
What interventions are being tested in trial NCT00601965?
The interventions under investigation include: Placebo (DRUG), Escitalopram (DRUG), Cognitive behavioral therapy (CBT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00601965?
This trial is sponsored by Veterans Medical Research Foundation, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00601965 being conducted?
This trial has 3 study locations across California, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Generalized Anxiety Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
-
Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4
RECRUITING · NA
-
Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD)
RECRUITING · NA
-
Massage for GAD: Neuroimaging and Clinical Correlates of Response
RECRUITING · NA
-
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RECRUITING · NA
-
Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.